Evidence map›Paper›PMID 42344721›Full record

ArticleAdvanced materials technologies2026

Performance of Hybrid and All-Inorganic Perovskite Direct X-Ray Imagers: Surpassing Commercial Standards.

Brandon Dunham, Shariar Motakef, Amlan Datta

Abstract read
In one paragraph

Article in Advanced materials technologies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brandon DunhamCapeSym, Inc., 6 Huron Drive, Natick, MA 01760, USA.
Shariar MotakefCapeSym, Inc., 6 Huron Drive, Natick, MA 01760, USA.
Amlan DattaCapeSym, Inc., 6 Huron Drive, Natick, MA 01760, USA.ORCID 0000-0003-2644-4905

Funding

High-Resolution Direct-Conversion X-ray Detectors for Low-Dose ImagingR44EB038123 · NIBIB · CAPESYM, INC. · PI Amlan Datta · 2025 to 2026
$1.8M
Low-Cost, Low-Dose Flat Panel X-ray Detectors with a Novel SemiconductorR44EB028208 · NIBIB · CAPESYM, INC. · PI DATTA, AMLAN · 2020 to 2021
$1.6M
NIBIB NIH HHS R44 EB028208NIBIB NIH HHS R44 EB038123
6 · The paper itself

Abstract

Solution-processed metal halide perovskites have rapidly emerged as promising candidates for direct X-ray imaging, yet fundamental comparisons between hybrid and all-inorganic systems in flat panel architectures remain missing. A systematic study of perovskite X-ray imagers (PeroXIs) based on methylammonium lead iodide and cesium lead bromide films integrated onto identical active pixel arrays is presented. Fully inorganic imagers demonstrate excellent performance characteristics, achieving high spatial resolution, contrast, sensitivity, and operational stability. While hybrid perovskites also show promising results, the all-inorganic systems exhibit characteristics that may be particularly advantageous for repeatable performance and therefore commercial deployment. Crucially, the all-inorganic PeroXI overcomes the long-standing trade-off between spatial resolution and detection efficiency that has limited X-ray detection technologies for decades, achieving high performance on both fronts. The results establish solution-processed inorganic perovskites as a scalable, high-performance platform capable of surpassing commercial standards, opening a new pathway toward low-cost, high-resolution, and low-dose X-ray imaging across medical, industrial, and scientific domains.

Indexed as

detectorflat panelperovskiteresolutionX-ray Imaging

Identifiers

PMID42344721
PMCPMC13290278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.